Asking the Right Questions About Synthetic Opioids
S&T's Master Question List for Synthetic Opioids consolidates information and knowledge gaps to better focus investments on the most useful R&D.
Breadcrumb
- Home
- About DHS
- Site Links
- Keywords
- Opioid
Opioid
Last Updated:
| Blog
Last Updated:
| Publication
S&T Master Question List for Synthetic Opioids
The Science and Technology Directorate developed this Master Question List to serve two primary objectives: 1) provide response communities with a simple interface of consolidated, scientifically vetted information in the context of daily operations; and 2) highlight for research and development communities the remaining critical knowledge gaps to focus investments with high operational priority and utility.
Last Updated:
| Press Releases
Feature Article: New Fentanyl Detection Standards Protect First Responders
The newly published standards will be put into effect almost immediately through a S&T-led research and development effort with PNNL.
Last Updated:
| Site Page
Opioid/Fentanyl Detection
S&T’s Opioid/Fentanyl Detection program is developing and evaluating advanced detection technologies and analytics to better target, interdict, and investigate illicit opioid and other narcotic smuggling into the U.S.
Last Updated:
| Site Page
Chemical, Biological and Explosive Defense R&D
S&T’s research and development support prevention and protective strategies, as well as the coordinated surveillance and detection of chemical, biological and explosive threats.
Last Updated:
| Press Releases
News Release: S&T Seeks Industry Participation in Battle Against Opioids
DHS S&T is working with the Pacific Northwest National Laboratory (PNNL) on a multi-phase study to improve detection of synthetic opioids.
Last Updated:
| Publication
ST Opioid/Fentanyl Detection Fact Sheet
S&T has established a program in collaboration with U.S. Customs and Border Protection to deliver improved drug detection capabilities.
Last Updated:
| Publication
Confronting the Opioid Crisis
Since President Donald J. Trump announced the Initiative to Stop Opioid Abuse and Reduce Drug Supply and Demand on March 19, 2018, the Department of Homeland Security (DHS) has embarked on an aggressive inter-agency operation to implement the president’s initiative and to stem the flow of opioids into U.S. communities.
Last Updated:
| Testimony
Written testimony of ICE for a Senate Homeland Security and Governmental Affairs Permanent Subcommittee on Investigations hearing titled “Combatting the Opioid Crisis: Exploiting Vulnerabilities in International Mail Security”
U.S. Immigration and Customs Enforcement (ICE) Homeland Security Investigations Office of Illicit Trade, Travel, and Finance Deputy Assistant Director Greg Nevano addresses the crisis of heroin and illicit fentanyl in the United States and the efforts of ICE to target, investigate, disrupt, dismantle and bring to justice the criminal elements responsible for the manufacturing, smuggling, and distribution of dangerous opioids.
Last Updated:
| Testimony
Written testimony of CBP for a Senate Homeland Security and Governmental Affairs Permanent Subcommittee on Investigations hearing titled “Combatting the Opioid Crisis: Exploiting Vulnerabilities in International Mail Security”
U.S. Customs and Border Protection (CBP) Office of Field Operations Executive Assistant Commissioner Todd Owen addresses the of CBP in combating the flow of dangerous illicit drugs, including synthetic opioids, into the United States, specifically through international mail and express consignment carrier shipments.